Abstract ED10-02: Identifying Collateral Vulnerabilities in the AKT pathway for Therapeutic Benefit - KIVIRID

Abstract ED10-02: Identifying Collateral Vulnerabilities in the AKT pathway for Therapeutic Benefit

Authors: A. Toker

Published: 2024-05-02

DOI: 10.1158/1538-7445.sabcs23-ed10-02

Source: Full article

Abstract

Abstract